IMS Health Announces Acquisition of Incential Software

Expands Leading-Edge SaaS Incentive Compensation Capabilities for Life Sciences

DANBURY, Conn.--(BUSINESS WIRE)--IMS Health has acquired Incential Software, an industry-leading Software-as-a-Service (SaaS) company based in Raleigh, NC, to advance its sales performance management capabilities for life sciences organizations worldwide. Incential delivers unique, cloud-based technology and services that integrate incentive compensation, data management and business intelligence applications for more effective, results-driven sales operations. The acquisition further extends IMS Health's leadership in helping clients transform their commercial models to meet shifting marketplace demands – with solutions that significantly streamline and accelerate incentive compensation reporting and management for improved ROI.

IMS Health will bring together its market-leading healthcare information, analytics, managed services and technology with Incential's proven suite of life sciences-optimized software solutions. The combination gives organizations immediate access to information and services to support critical aspects of sales force strategy, planning and implementation. IMS Health's innovative incentive compensation offerings, which include integrated payer, provider and anonymous patient-level metrics, drive a holistic approach to rewarding sales teams.

"Every life sciences company, across every commercial operation, is looking to tap the power of data-driven, technology-enabled solutions to make their sales compensation plans more efficient, effective and aligned," said Lisa Kerber, vice president and general manager, Commercial Effectiveness Services, IMS Health. "Through this acquisition, we're bringing together a comprehensive set of evidence-based capabilities and services to transform the way our clients plan and execute their commercial programs."

Incential complements IMS Health's strategy of connecting knowledge across healthcare to help organizations access and interpret the right information, and drive performance through better decisions and actions. Incential's solutions become part of IMS One, the company's commercial platform that combines IMS Health and third-party data for sales, marketing and performance management activities. Flexible and scalable, IMS One's cloud-based information and services enable clients to benefit from lower costs, faster implementation and increased speed to insight.

This acquisition expands the company's growing portfolio of SaaS solutions that help organizations plan, execute and assess customer engagement activities across digital and traditional channels. Earlier this year, IMS Health acquired 360 Vantage to extend its multi-channel CRM software capabilities; Appature, which has developed an innovative and patented relationship marketing platform; and Semantelli, a leading provider of social media analytics for the global healthcare industry.

About Incential Software

Incential Software is a leading provider of sales performance management software and services to pharmaceutical, biotech and medical device companies. Since 1998, Incential's suite of incentive compensation, data management and business intelligence solutions combined with its staff of experienced consultants from the life sciences industry have made Incential the choice of over 200 sales forces and 25,000 representatives for solutions that drive sales performance. Incential has facilities in Raleigh, NC and Phoenix, AZ. For more information, please visit Incential's website at www.incential.com.

About IMS Health

IMS Health is a leading worldwide provider of information, technology and services dedicated to making healthcare perform better. With a global technology infrastructure and unique combination of real-world evidence, advanced analytics and proprietary software platforms, IMS Health connects knowledge across all aspects of healthcare to help clients improve patient outcomes and operate more efficiently. The company's expert resources draw on data from nearly 100,000 suppliers, and on insights from more than 40 billion healthcare transactions processed annually, to serve more than 5,000 healthcare clients globally. Customers include pharmaceutical, medical device and consumer health manufacturers and distributors, providers, payers, government agencies, policymakers, researchers and the financial community. Additional information is available at www.imshealth.com.

As a global leader in protecting individual patient privacy, IMS Health uses anonymous healthcare data to deliver critical, real-world disease and treatment insights. These insights help biotech and pharmaceutical companies, medical researchers, government agencies, payers and other healthcare stakeholders to identify unmet treatment needs and understand the effectiveness and value of pharmaceutical products in improving overall health outcomes.

Contacts

IMS Health
Kelly Massimini, + 1-484-567-6411
[email protected]

 

Suggested Articles

There's no evidence personal patient information leaked during the 11-week breach, but the same can't be said about Sangamo's own secrets.

Through a new online tracker, AllTrials names sponsors who fail to report clinical trial results on time per the FDAAA Final Rule.

The new solution aims to streamline the incorporation of human genomic data into clinical trial designs.